Works matching DE "RADIOIMMUNOTHERAPY"
Results: 557
Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan-1) for nuclear medicine preclinical trials on spontaneous tumours.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 932, doi. 10.1111/vco.12233
- By:
- Publication type:
- Article
Development of a two-antibody model for the evaluation of copper-64 radioimmunotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2004, v. 2, n. 2, p. 82, doi. 10.1111/j.1476-5810.2004.00041.x
- By:
- Publication type:
- Article
A two-antibody model for copper-64 radioimmunotherapy: biodistributions and tumor dosimetry in a mouse model of cancer.
- Published in:
- 2004
- By:
- Publication type:
- Abstract
Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments.
- Published in:
- Acta Neurochirurgica, 2019, v. 161, n. 6, p. 1109, doi. 10.1007/s00701-019-03882-9
- By:
- Publication type:
- Article
Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin's Lymphoma: A Review of the Evidence.
- Published in:
- Oncologist, 2009, p. 17, doi. 10.1634/theoncologist.2009-S2-17
- By:
- Publication type:
- Article
Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma.
- Published in:
- Oncologist, 2009, p. 4, doi. 10.1634/theoncologist.2009-S2-4
- By:
- Publication type:
- Article
Introduction.
- Published in:
- Oncologist, 2009, p. 1, doi. 10.1634/theoncologist.2009-S2-1
- By:
- Publication type:
- Article
Summary.
- Published in:
- Oncologist, 2009, p. 52, doi. 10.1634/theoncologist.2009-S2-52
- By:
- Publication type:
- Article
Radioimmunotherapy for Stem Cell Transplantation in Non-Hodgkin's Lymphoma: In Pursuit of a Complete Response.
- Published in:
- Oncologist, 2009, p. 41, doi. 10.1634/theoncologist.2009-S2-41
- By:
- Publication type:
- Article
Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma.
- Published in:
- Oncologist, 2008, v. 13, n. 6, p. 657, doi. 10.1634/theoncologist.2008-0020
- By:
- Publication type:
- Article
Commentary: Let the Tail Wag the Dog: The Case for Radioimmunotherapy of Low-Grade Follicular Lymphoma.
- Published in:
- Oncologist, 2008, v. 13, n. 6, p. 655, doi. 10.1634/theoncologist.2008-0113
- By:
- Publication type:
- Article
Biocompatibility of a Novel Avidin-Agarose Adsorbent for Extracorporeal Removal of Redundant Radiopharmaceutical From the Blood.
- Published in:
- Artificial Organs, 2007, v. 31, n. 3, p. 208, doi. 10.1111/j.1525-1594.2007.00366.x
- By:
- Publication type:
- Article
The 44th Annual Scientific Meeting Adelaide Convention Centre April 25-28, 2014.
- Published in:
- 2014
- Publication type:
- Proceeding
Editorial: Radioimmunotherapy—Translational Opportunities and Challenges.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01301
- By:
- Publication type:
- Article
Turning "Cold" Into "Hot" Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00163
- By:
- Publication type:
- Article
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00162
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 1, doi. 10.1038/bmt.2013.72
- By:
- Publication type:
- Article
Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 11, p. 1397, doi. 10.1038/bmt.2012.62
- By:
- Publication type:
- Article
Preferences of patients and physicians concerning treatment options for relapsed follicular lymphoma: a discrete choice experiment.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 962, doi. 10.1038/bmt.2010.225
- By:
- Publication type:
- Article
Radioimmunotherapy with <sup>90</sup>Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 4, p. 552, doi. 10.1038/bmt.2010.169
- By:
- Publication type:
- Article
Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: Potential relationship to post-therapy tumor angiogenesis and recurrence.
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 2, p. 158, doi. 10.1002/ijc.11059
- By:
- Publication type:
- Article
Management of Patients With Histologic Transformation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic Significance of Pretreatment F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using <sup>131</sup>I-Rituximab.
- Published in:
- Acta Haematologica, 2013, v. 130, n. 2, p. 74, doi. 10.1159/000346436
- By:
- Publication type:
- Article
Management pathway for patients with cervical cancer in the Auckland region 2003-2007.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2011, v. 55, n. 3, p. 337, doi. 10.1111/j.1754-9485.2011.02276.x
- By:
- Publication type:
- Article
'Innovative agent' for lymphoma.
- Published in:
- British Journal of Hospital Medicine (17508460), 2008, v. 69, n. 7, p. 376
- By:
- Publication type:
- Article
Follicular lymphoma trial gives 'dramatic results'.
- Published in:
- British Journal of Hospital Medicine (17508460), 2008, v. 69, n. 2, p. 72
- Publication type:
- Article
Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 1, p. 3, doi. 10.1111/j.1365-2141.2006.05975.x
- By:
- Publication type:
- Article
<sup>188</sup>Re or <sup>90</sup>Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 4, p. 604, doi. 10.1111/j.1365-2141.2005.05663.x
- By:
- Publication type:
- Article
THE EMERGING ROLE OF RADIOIMMUNOTHERAPY IN HAEMATOLOGICAL MALIGNANCIES.
- Published in:
- British Journal of Haematology, 2000, v. 108, n. 4, p. 679, doi. 10.1046/j.1365-2141.2000.01926.x
- By:
- Publication type:
- Article
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term efficacy of Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 12, p. 1985, doi. 10.1007/s00277-014-2145-6
- By:
- Publication type:
- Article
Secondary haematological malignancies after radioimmunotherapy.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with I-anti-CD20 antibody and stem cell rescue.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 11, p. 1307, doi. 10.1007/s00277-011-1199-y
- By:
- Publication type:
- Article
Clinical outcomes of post-remission therapy using (90)yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy.
- Published in:
- Annals of Hematology, 2007, v. 86, n. 2, p. 81, doi. 10.1007/s00277-006-0207-0
- By:
- Publication type:
- Article
Recent advances of injectable radiopharmaceuticals for nuclear imaging and therapy: a new era in nuclear medicine.
- Published in:
- Materials Technology, 2015, v. 30, p. B250, doi. 10.1080/10667857.2015.1104829
- By:
- Publication type:
- Article
Recent advances of injectable radiopharmaceuticals for nuclear imaging and therapy: a new era in nuclear medicine.
- Published in:
- Materials Technology, 2015, v. 30, n. B4, p. B250, doi. 10.1080/10667857.2015.1104829
- By:
- Publication type:
- Article
Immune Activation Effects at Different Irradiated Sites and Optimal Timing of Radioimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer: a Real-World Analysis.
- Published in:
- Biological Procedures Online, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s12575-023-00217-y
- By:
- Publication type:
- Article
Camptothecin enhances <sup>131</sup>I-rituximab-induced G1-arrest and apoptosis in Burkitt lymphoma cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of S values for I<sup>131</sup> and Y<sup>90</sup> based on the Digimouse voxel phantom.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Radioimmunotherapy with.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 2, p. 136, doi. 10.1111/j.1743-7563.2011.01393.x
- By:
- Publication type:
- Article
Thalassemia and other hemoglobinopathies among anemic individuals in Metro Manila, Philippines and their intake of iron supplements.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effectiveness of Combined I-chTNT and Radiofrequency Ablation Therapy in Treating Advanced Hepatocellular Carcinoma.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 71, n. 2, p. 777, doi. 10.1007/s12013-014-0262-4
- By:
- Publication type:
- Article
Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application.
- Published in:
- Molecular Imaging, 2003, v. 2, n. 1, p. 1, doi. 10.1162/153535003765276237
- By:
- Publication type:
- Article
FDG PET/CT and Dosimetric Studies of <sup>177</sup>Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
- Published in:
- 2022
- By:
- Publication type:
- journal article